Literature DB >> 16013543

Multiple endocrine neoplasia type I in a cat.

S Brent Reimer1, Augusta Pelosi, Joseph D Frank, Barbara A Steficek, Matti Kiupel, Joe G Hauptman.   

Abstract

A 13-year-old 4.6-kg (10.2-lb) neutered male domestic long hair cat was evaluated because of a history of lethargy, exercise intolerance, and ventroflexion of the cervical portion of the vertebral column. After extensive assessment at the Veterinary Teaching Hospital at Michigan State University, the clinical signs were attributed to an aldosterone-secreting tumor of the adrenal gland. Subsequently, an insulin-secreting tumor of the pancreas as well as a functional parathyroid gland adenoma were diagnosed. All 3 masses were surgically removed, and the cat made a full recovery with complete resolution of clinical signs. The syndrome of multiple endocrine neoplasia is well described in humans, and the heritability of the condition has been confirmed. In cats and other species with 1 or more endocrine neoplasms, it is important to perform thorough clinical assessments of patients to identify other endocrine organs that may also be affected concurrently with neoplastic disease.

Entities:  

Mesh:

Year:  2005        PMID: 16013543     DOI: 10.2460/javma.2005.227.101

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Multiple endocrine neoplasia-like syndrome in 24 baboons (Papio spp.).

Authors:  Alexandra Confer; Michael A Owston; Shyamesh Kumar; Edward J Dick
Journal:  J Med Primatol       Date:  2018-09-06       Impact factor: 0.667

2.  Use of contrast-enhanced ultrasonography for the detection of a feline insulinoma.

Authors:  Mario Cervone; Mathieu Harel; Emilie Ségard-Weisse; Emilie Krafft
Journal:  JFMS Open Rep       Date:  2019-09-23

3.  Clinical and Pathological Features of Pheochromocytoma in the Horse: A Multi-Center Retrospective Study of 37 Cases (2007-2014).

Authors:  D Luethy; P Habecker; B Murphy; R Nolen-Walston
Journal:  J Vet Intern Med       Date:  2015-11-27       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.